—
POC (Point-of-Care) diagnostics is an emerging trend in the European healthcare industry. Its primary driver is the effort by clinics and other healthcare providers to offer speedy and effective diagnostic results. Technological advancements have brought about low-cost and high-quality medical solutions aimed towards lab automation & miniaturization. Patients are also increasingly becoming aware of POC diagnostics. Moreover, the incidence of target diseases like diabetes, hypertension, cardiovascular disorders, etc. is on the rise. Burgeoning geriatric population augments the need for home care and monitoring. These factors are triggering growth of the Europe POC diagnostics industry.Browse Full Research Report With TOC on https://www.radiantinsights.com/research/europe-poc-diagnostics-industry-2016
The industry is split into various categories on the basis of products, end-users, and countries. Infectious diseases, cardiac markers, hospital glucose testing, hematology, decentralized clinical chemistry, and blood gas/electrolytes are some of the product types. Others comprise drug abuse testing, rapid diagnostic tests, coagulation, primary care systems, urinalysis, fertility, and OTC (Over-The-Counter).
Glucose testing held the largest market share (over 59%) in 2014. This owes to rising incidences of diabetes resulting in use by hospitals as well as the home healthcare segment (Self Blood Glucose Monitoring). Cardiac markers offer high accuracy. They are used for managing chronic cardiac ailments. Infectious diseases are likely to grow at a robust rate in the coming years.
Request A Sample Copy Of This Report at: https://www.radiantinsights.com/research/europe-poc-diagnostics-industry-2016/request-sample
End-users encompass clinics, home healthcare, hospitals, laboratories, assisted living healthcare facilities, and others. Clinics have held a dominant position in the years gone by. This is attributed to high volumes of medical procedures performed in them. Rise of rapid clinics – clinics that facilitate 24-hours, affordable primary healthcare, will have a favorable effect on the growth of this segment. Main countries in the European POC diagnostics industry are Germany, France, Portugal, Spain, UK, Turkey, Italy, Benelux Union, and Scandinavia. The remainder falls into ‘Rest of Europe’. Germany is a prominent consumer of POC diagnostics in Europe. It is characterized by favorable regulatory environment and superior healthcare infrastructure. The large geriatric populace is also conducive to this country’s growth. Key players in the Europe POC diagnostics industry include F. Hoffmann-La Roche, Bayer Healthcare, Abbott Laboratories, and Johnson & Johnson. Alere Inc. and Danaher Corporation are also important participants.
Browse All Reports of This Category at: https://www.radiantinsights.com/catalog/pharmaceuticals-and-healthcare
About Radiant Insights,Inc
Radiant Insights is a platform for companies looking to meet their market research and business intelligence requirements. We assist and facilitate organizations and individuals procure market research reports, helping them in the decision making process. We have a comprehensive collection of reports, covering over 40 key industries and a host of micro markets. In addition to over extensive database of reports, our experienced research coordinators also offer a host of ancillary services such as, research partnerships/ tie-ups and customized research solutions.
Contact Info:
Name: Michelle Thoras
Email: Send Email
Organization: Radiant Insights, Inc
Address: 28 2nd Street, Suite 3036, San Francisco, CA 94105, United States
Phone: 1-415-349-0054
Website: https://www.radiantinsights.com/research/europe-poc-diagnostics-industry-2016
Release ID: 123902